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ABSTRACT 
Local anesthetic systemic toxicity (LAST) is a rare complication of administering 
local anesthetic medications.  However, this complication is potentially deadly, especially 
without prompt and correct treatment.  Due to the rarity of LAST and the fact that its 
treatment differs from the conventional treatment of cardiac arrest, the authors sought a 
best practice recommendation to guide its treatment.  While the most effective treatment 
for LAST has been well established, a thorough review of literature and survey of clinical 
preceptors demonstrated that most providers have not encountered LAST in clinical 
practice.  Additionally, lipid emulsion therapy is a somewhat controversial treatment 
amongst some providers, even though its effectiveness is well documented.   
This doctoral project sought to develop a best practice recommendation to guide 
the treatment of LAST events and increase the confidence of providers in their ability to 
recognize and treat LAST.  The recommendation was developed after a thorough review 
of the literature.  The information was used to create a report of findings that were 
presented to a panel of experts.  Feedback from the expert panel revealed that the 
respondents have not encountered a LAST event in their clinical practice.  They all 
agreed that this practice recommendation would potentially help to guide the correct 
treatment of LAST.  Their feedback, along with the report of findings was subsequently 
used to develop an executive review that was sent to a hospital affiliated with the Nurse 
Anesthesia Program at The University of Southern Mississippi in which the evaluation 
was performed.  The executive summary also included an education module for the 
anesthesia staff. 
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CHAPTER I - INTRODUCTION 
Local anesthetic systemic toxicity (LAST) is a rare, but potentially fatal 
complication of administering local anesthetic medications.  LAST can quickly lead to 
the central nervous system and cardiac compromise (Tetzlaff, 2000).  LAST treatment 
differs in a few key areas from conventional treatment of cardiac arrest and, therefore, 
should be approached in a different, more precise manner (Dillane & Finucane, 2009).  
For example, calcium channel blockers and lidocaine are commonly used to treat 
arrhythmias that arise in a patient with cardiac compromise (Tetzlaff, 2000).  However, 
these medications will lead to a further decline in the patient experiencing a LAST event.  
While the most effective treatment for LAST has been well established, both review of 
literature and survey of clinical preceptors have shown that its rarity makes it a condition 
that most providers have not encountered in clinical practice (Manavi, 2010; Nedialkov, 
Umadhav, Valdes, & Campbell, 2018).  According to a 2012 study, “the incidence (per 
1000 blocks) of adverse events across all peripheral regional anesthetics was 1.8 (95% 
confidence interval [CI]” (Sites, Taenzer, Herrick, & Gilloon, 2012, p. 478).  
Additionally, lipid emulsion has been shown to drastically improve resuscitation 
following local anesthetic systemic toxicity although its use remains controversial among 
anesthesia providers (Nedialkov et al., 2018). 
Problem Description 
The operating room is a dynamic healthcare practice setting.  Due to this ever-
changing environment, crises dictate a rapid response from healthcare professionals.  The 
occurrence of LAST is rare (Sites et al., 2012).  Failure to treat or incorrect treatment of 
LAST has the potential to result in patient injury or death (Barash et al., 2017).  A review 
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of the literature and informal interviews with anesthesia providers revealed that a 
knowledge deficit exists surrounding the treatment of LAST (Corcoran et al., 2006, p. 
1324-1325; Appendix A).  Potential negative consequences of the failure to manage 
LAST include central nervous system (CNS) toxicity, cardiac toxicity, and death (Dillane 
& Finucane, 2009).  To address this gap in knowledge, a best practice recommendation 
was compiled based on current evidence-based literature.  The best practice 
recommendation was further used to create a treatment protocol that was presented to 
anesthesia administration at a University of Southern Mississippi (USM) clinical affiliate 
hospital, along with an educational tool that can be used for certified registered nurse 
anesthetist (CRNA) education of the proposed protocol.  
Available Knowledge 
Local Anesthetics 
Local anesthetics are medications used to stop the transmission of pain sensation 
by blocking the conduction of nerve impulses along nerve fibers (Lin & Liu, 2017, p. 
564).  To understand the pharmacodynamics of local anesthetics, one must have a basic 
knowledge of nerve conduction.  The transmission of a nerve impulse relies on the 
existence of an electrical gradient across the nerve cell membrane.  This gradient is 
established by the influx and efflux of sodium and potassium ions.  The propagation of a 
nerve impulse begins when a sufficient electrical stimulus causes a change in the 
membrane potential to the level of threshold potential.  This phenomenon leads to 
depolarization, which is a rapid influx of sodium ions through a voltage-gated sodium 
channel from the extracellular to the intracellular space.  This voltage-dependent gate is 
located on the intracellular portion of the cell membrane.  Local anesthetics work by 
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reversibly inhibiting the influx of sodium through these voltage-gated sodium channels, 
preventing the transmission of pain signals (Lin & Liu, 2017). 
Benefits of Local Anesthetics Use in Anesthesia Practice 
Neuraxial Anesthesia 
Many studies have focused on the differences in morbidity and mortality 
following surgical procedures using general vs neuraxial anesthesia.  A meta-analysis 
including over 3,000 patients found that neuraxial anesthesia (subarachnoid and epidural 
anesthesia) was associated with a low risk of death in the 30 days immediately following 
surgery (Barash et al., 2017).  Neuraxial anesthesia was also found to decrease the risk of 
post-operative pneumonia.  Another meta-analysis involving over 18,000 patients who 
had undergone surgery to treat hip fracture found that the use of neuraxial anesthesia was 
associated with decreased intra-hospital death and pulmonary complications (Barash et 
al., 2017).  
Neuraxial anesthesia has also shown improved outcomes in specific patient 
populations.  A small single-institution study found decreased postoperative pulmonary 
complications, arrhythmias, and shorter stays in intensive care for patients following 
lower extremity amputations when regional anesthesia was used instead of general 
anesthesia (Barash et al., 2017).  Regional anesthesia has also been associated with 
decreased respiratory events in patients with chronic obstructive pulmonary disease 
(COPD), a condition that is known to cause complications in general anesthetics.  A 
study of more than 14,000 patients undergoing knee arthroplasty found fewer wound 
infections, pneumonia, infections, and blood transfusions following regional anesthesia in 
comparison to general anesthesia (Barash et al., 2017).  This same study also found a 
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shorter period of hospital stay for those patients who received neuraxial anesthesia.  
Interestingly, epidural anesthesia may be associated with an increased survival rate 
following cancer surgeries.  The improved summary is attributed to the avoidance of 
immunosuppression that can occur with the use of general anesthesia and postoperative 
opioids (Barash et al., 2017).  Epidural and spinal anesthesia are the techniques of choice 
for analgesia for labor and cesarean section, due to the prevention of unwanted drug 
delivery to the fetus. 
Peripheral Nerve Blockade 
Regional anesthesia allows the provider to administer long-acting anesthesia and 
analgesia to a specific site of the body.  Regional anesthetic techniques can be 
implemented in a wide variety of surgical procedures.  According to Barash et al. (2017), 
peripheral nerve blockade can reduce mortality and morbidity, and the need for additional 
surgical intervention following major surgical procedures.  Peripheral nerve blockade is 
also associated with greater analgesia and improved patient satisfaction.  Another study 
of randomized control trials demonstrated that single-shot peripheral nerve blocks were 
associated with decreased pain, decreased the need for a “rescue” pain medication, 
decreased nausea and vomiting, and increased patient satisfaction scores (Cousins, Carr, 
Horlocker, & Bridenbaugh, 2009).  Additionally, an observational study of ambulatory 
patients demonstrated a 76% decrease in unplanned hospitalizations following anterior 
cruciate ligament (ACL) repair surgery (Cousins et al., 2009).  Continuous indwelling 
peripheral nerve blocks offer the additional benefit of extending the analgesia farther into 
the postoperative period (Barash et al., 2017).  
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Local Anesthetic Systemic Toxicity 
LAST is a life-threatening event that results from local anesthetic reaching 
significant systemic circulating levels.  The symptoms of LAST most frequently appear 
within the first few minutes of injection of a local anesthetic.  The toxicity most likely 
occurs because of inadvertent intravascular injection of local anesthetic or injection of 
higher than the therapeutic dose (Barash et al., 2017).  LAST symptoms occur in the 
central nervous system and/or the cardiovascular system.  “The effects on the CNS are 
determined by the plasma concentration of the local anesthetic.  At low plasma 
concentration, mild disturbances to the sensory systems appear.  As the plasma 
concentration increases, CNS excitation and seizure activities predominate.” (Barash et 
al., 2017, p. 575).  Untreated, these CNS symptoms can lead to respiratory depression, 
coma, and eventually death.  Cardiovascular symptoms are seen at a higher plasma 
concentration than that which leads to CNS symptoms (Barash et al., 2017).  While all 
local anesthetics can cause hypotension, dysrhythmias and myocardial depression, more 
potent agents, such as bupivacaine, ropivacaine, and levobupivacaine, are predisposed to 
devastating outcomes such as cardiovascular collapse and complete heart block (Barash 
et al., 2017).  “Surveys from France and the United States of over 280,000 cases 
involving regional anesthesia show an incidence of seizures of approximately 1/10,000 
with an epidural injection, and 7/10,000 with peripheral nerve blocks” (Barash et al, 
2017, p. 453).  This study magnifies the benefit versus risk ratio associated with regional 
anesthesia.   
The exact mechanism that induces LAST is not clearly understood.  To quote 
Clinical Anesthesia (Barash, 2017), “The underlying pathophysiology responsible for 
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local anesthetic-induced cardiovascular collapse has not been fully established” (Barash 
et al., 2017, p. 576).  “Local anesthetics readily cross the blood-brain barrier and, as a 
result, central nervous system toxicity can occur with systemic absorption or inadvertent 
intravascular injections” (Barash et al., 2017, p. 575).  The ease of local anesthetic 
diffusion across the blood-brain barrier explains why in some cases, confusion and 
seizure activity precedes cardiovascular symptoms.  An especially dangerous drug that 
can present with cardiac symptoms is bupivacaine.  “Bupivacaine has an inherently 
greater affinity for binding resting and inactivated cardiac sodium channels than 
lidocaine” (Barash et al., 2017 p. 577). 
Measures to Prevent LAST 
The optimal approach to treating LAST is to prevent it.  Some issues with the 
information on LAST treatment and prevention are associated with its infrequency and 
the ethical issues of studying it.  According to a 2011 National Association of 
Biotechnology Information article by Sandhya Yaddanapudi (para. 2),  
… providers should be aware of and adhere to maximum dose recommendations 
of various local anesthetics.  The current recommendations are not entirely based 
on scientific evidence.  They have been extrapolated from animal experiments, 
case reports of LAST, and some pharmacokinetic studies because human 
randomized control trials (RCT) are difficult to conduct for ethical reasons.   
With the morbidity and mortality associated with LAST, every effort should be made to 
prevent intravascular injection.  According to the same study,  
No single intervention can reliably eliminate the risk of LAST.  Several steps 
must be taken to avoid intravascular injection and elevated blood concentration of 
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the LA during the performance of the regional technique.  Aspiration before 
injection of LA and the use of an intravascular marker such as epinephrine 
reduces the likelihood of accidental intravascular injection to a large extent. 
(Yaddnapudi, 2011, para. 2)  
The use of ultrasound-guided regional anesthesia (UGRA) is a topic that is being 
explored as a best practice guideline to prevent LAST.  In theory, visualization of 
anatomic structures and medication spread should reduce adverse outcomes associated 
with regional anesthesia, including LAST.  Due to the extreme rarity of this complication, 
a statistically significant difference between nerve localization techniques, if indeed any 
difference exists, will likely never be realized.  Evidence is conflicting regarding whether 
UGRA results in true reduction of LAST (Neal & Richard, 2010). 
Evidence-Based Practice for Treatment of LAST 
The American Society of Regional Anesthesia and Pain Medicine (ASRA) 
updated the checklist for the management of LAST as recently as 2017.  The 
recommendations are described as “fundamentally different from conventional 
cardiopulmonary resuscitation. Insofar as toxic cardiomyopathy differs from other causes 
of CV collapse” (Neal & Barrington, 2017, para. 5).  These guidelines recommend early 
airway support over immediate cardiac support.  This approach prioritizes the prevention 
of hypercarbia and subsequent acidosis that can potentiate LAST.  This article states 
succinctly, “Successful treatment of LAST seeks to effectively moderate or reverse the 
mechanisms underlying the local anesthetic toxicity” (Neal & Barrington, 2017, para. 6).  
Data retrieved from rat studies reinforce the practice of administering small doses of 
epinephrine when patient condition indicates (1mcg/kg or less) (Barrington, 2017).  
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“Lipid therapy is recommended at the first sign of arrhythmia, prolonged seizures, or 
rapid clinical deterioration of the patient” (Neal & Barrington, 2017, para. 8).  Multiple 
case reports demonstrate successful resuscitation following LAST when intralipid is used 
as early treatment (Valera & Burns, 2010).  However, the use of intralipid therapy 
remains controversial among anesthesia providers (Nedialkov et al., 2018). 
Existing Protocols 
As stated before, in 2017 the ASRA updated the checklist for the treatment of 
local anesthetic system toxicity treatment.  Recommendations by The Association of 
Anaesthetists of Great Britain and Ireland (2010) and Medscape (2019) echo the 
treatment described by the ASRA.  The initial treatment suggested is to stop or limit the 
insulating substance and get assistance.  If serious signs of LAST occur, consider lipid 
emulsion therapy immediately (ASRA 2017).  Due to the gravity of a cardiovascular 
event from LAST, notifying the nearest cardiopulmonary bypass team is also 
recommended.  Providers are encouraged to ventilate with 100% oxygen, avoid 
hyperventilation, and insert advanced airway if needed to control seizures. 
Benzodiazepines are the preferred method of seizure management.  Propofol is to be 
avoided due to its cardiac depressive properties.  If the patient weighs greater than 70 
kilograms, a bolus of 100 milliliters 20% lipid emulsion over a 2-3-minute period is 
recommended, followed by an infusion of 200-250 milliliters over 15-20 minutes.  For a 
patient less than 70 kilograms a bolus of 1.5 milligram/kilogram (ideal body weight) lipid 
emulsion over 2-3 minutes, followed with an infusion of 0.25 milligram/kilogram is 
recommended.  With a dosing limit of 12 milligram/kilogram, the total volume of lipid 
emulsion can approach 1 liter in a prolonged resuscitation (ASRA, 2017).  
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Protocol Creation 
Having standardized protocols in place for crises is imperative.  The airline 
industry has gained a record of safety that has become an example of success in other 
professions.  This success is largely attributed to protocols.  Despite success in other 
industries, process standardization in healthcare has been slow to gain traction or to 
demonstrate a positive impact on the safety of care (Leotsakos, Zheng, & Croteau, 2014).  
The human variables of practitioners and sick patients are complex and often not easily 
predicted.  A study in the International Journal for Quality in Health Care states, “In 
health care, evidence shows that divergent patterns of care result in worse clinical 
outcomes and that removal of variance can reduce risk, and costs” (Leotsakos et al., 
2014, para. 8). 
Rationale 
Evidence shows many benefits of local anesthetic use, including decreased length 
of hospital stay, increased pain control, decreased pulmonary complications, decreased 
opioid use, and even increased survival rates in some cases (Baresh et al., 2017).  For 
these reasons, the practice of regional anesthesia is on the rise.  As with any anesthetic 
procedure, risks must be acknowledged and properly managed.  True local anesthetic 
systemic toxicity is a rare event; thus, most anesthesia providers have not encountered it 
in training or clinical practice.  This inconsistency leads to a possible gap in provider 
understanding of the proper treatment for LAST.  Evidence shows that the use of 
checklists or protocols can improve the selection of the appropriate treatment modality in 
uncommonly encountered clinical events (Harrison, Manser, Howard, & Gaba, 2006; 
Ziewacz, Ariaga, Bader et al., 2011).  Therefore, a LAST treatment checklist was 
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presented to ensure an effective treatment in the event of LAST.  The evidence-based 
research indicates that this protocol is readily available in all operative environments 
where local anesthetics are to be administered (ASRA, 2017). 
Specific Aims 
From a review of the evidence and informal interviews with anesthesia providers, 
the authors have found that a knowledge deficit exists surrounding the treatment of LAST 
(Corcoran et al., 2006) (Appendix-C).  This project aimed to develop a best practice 
guideline to direct the appropriate treatment of LAST.  The rarity at which LAST is 
encountered in clinical practice predisposes providers to a gap in experience with its 
treatment.  This project aimed to bridge that gap by providing an easily accessible and 
concise aid that can be readily used to guide providers in the treatment of local anesthetic 
systemic toxicity.  The intent is that this checklist will increase providers’ confidence in 
their ability to treat LAST, encouraging local anesthetics to use in their clinical practice.   
DNP Essentials 
This DNP project fulfilled all eight DNP Essentials set forth by the American 
Colleges of Nursing (AACN) (2006), as referenced in Appendix E.  These essentials 
describe the fundamental competencies that are required for advanced practice nurses.  
The essentials also set forth the required elements of the curriculums of DNP programs. 
Summary 
Through informal interviews with anesthesia administration and CRNAs at a 
USM clinical affiliate hospital, it was determined that the hospital lacked a best practice 
clinical policy regarding the treatment for LAST, a rare yet potentially deadly 
complication of local anesthetic administration.  Therefore, available knowledge was 
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examined to determine the best practice for the treatment of LAST.  The research was 
consistent on the appropriate treatment for LAST (Association of Anesthetists of Great 
Britain and Ireland [AAGBI], 2010; ASRA, 2017), and the American Society of Regional 
Anesthesia and Pain Medicine has developed a checklist that includes the major points of 
LAST treatment (ASRA, 2017). 
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CHAPTER II – METHODS 
Context 
A current best practice investigation regarding local anesthetic systemic toxicity 
was conducted at a USM affiliate hospital in Mississippi.  Through informal interviews 
with anesthesia administration and CRNAs and a review of literature, it was determined 
that some hospitals lacked a best practice clinical policy regarding the treatment for 
LAST.  The 260-bed facility reported in 2016 an average total daily census of 134.6 
patients.  The hospital reported, 215 babies delivered in 2016 (Mississippi State 
Department of Health, 2018). According to Jason Coleman, CRNA, “this hospital 
provides surgical services, utilizing regional anesthesia with the administration of local 
anesthetics” (J. Coleman, personal communication). 
Intervention, Study of Intervention, and Measures 
Upon completion of clinical rotations at various surgical facilities in Mississippi, 
it was recognized that no distinct policy existed at a clinical affiliate hospital for the 
treatment of local anesthetic systemic toxicity.  In addition, an informal survey of 
anesthesia providers demonstrated little experience with the treatment of LAST.  
Therefore, available knowledge was examined and synthesized to determine the best 
practice for the treatment of LAST.  A literature search was performed to analyze best 
practice guidelines for LAST prevention and treatment.  A secondary search was done to 
explore the benefits of using checklists, protocols, and/or cognitive aids in the treatment 
of anesthetic emergencies.  Several databases including CINAHL, Cochrane, Google 
Scholar, and PubMed were used to find relevant articles. The following search terms 
were used: local anesthetic systemic toxicity, LAST treatment, LAST prevention, 
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anesthesia emergency protocol, and anesthesia cognitive aids.  The initial search had 
limitations of publication dates between 2008 and 2018.  This search resulted in 752 
articles.  The articles that were included in this project were chosen based on their 
relevance to the topic studied.  Also, leading textbooks in the field of anesthesia were 
reviewed and the applicable sections selected for use in this project.  
The literature review included the ASRA Checklist for Treatment of Local 
Anesthetic Systemic Toxicity and evidence that supports the steps on the list.  Additional 
protocols by Medscape (2019) and The Association of Anaesthetists of Great Britain and 
Ireland (2010) concur on the appropriate LAST treatment.  These protocols, along with 
the supporting peer-reviewed literature was used as a guide for the development of a 
policy recommendation regarding the treatment of LAST. Once the project was approved 
by the committee, it was submitted to the Institutional Review Board (IRB) with the 
intention to seek exemption for this project (IRB Protocol # 19-327, Appendix A). 
The available knowledge was synthesized to compile a report of findings, as 
shown in Appendix C.  This report of findings, along with the ASRA checklist for 
treatment of local anesthetic systemic toxicity was presented to a panel of experts 
(Appendix A).  This panel of experts was assembled by way of face-to-face invitation.  
This group of the chosen facility personnel included the Chief CRNA, a pharmacist, a 
supervising registered nurse, and a health policy expert.  The Chief CRNA was asked to 
join the panel of experts due to his expertise in anesthesia, as well as, his familiarity with 
the facility and its available resources.  A pharmacist was included on the panel because 
of their pharmacological expertise and their knowledge of the availability, price, and 
storage requirements of medications.  The panel also included a registered nurse who 
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supervises the block/preparation area, due to their knowledge of the block procedures and 
the resources available in this area where local anesthetics are frequently administered.  
Finally, the healthcare policy expert was included, because of her expertise and 
experience with health policy creation. 
An evaluation tool, shown in Appendix D, was developed by the ASRA and was 
used to gather feedback on the presented data.  The evaluation included the clarity of the 
presented information, the quality of the information, and relevance to practice.  In 
addition, consideration was given to whether or not the best practice should be 
implemented, a space for additional comments was provided.  The feedback was 
reviewed and no revisions to the policy recommendation were deemed necessary, nor to 
the executive summary (Appendix F).  The executive summary containing the report of 
findings, the policy recommendation, and the associated educational module were then 
presented to the Chief CRNA for consideration of implementation.  The participants were 
sent an anonymous survey link and asked not to include any identifying information on 
their surveys in order to keep their comments confidential.  Data was kept on a personal 
password-protected laptop, and files were kept in a locked drawer.  Data was retained 
until project completion, then all files were permanently deleted from the storage device 
and written documentation was shredded.  
Analysis 
Qualitative data was collected using an evaluation tool (Appendix D).  The data 
was gathered in a face-to-face manner along with a presentation of the policy.  The 
information was reviewed and entered into Table 1 where responses were given 
quantitative values.  The data processing was accomplished before presenting the policy 
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recommendation along with the executive summary (Appendix F) along with an 
educational module for the CRNAs.  Statistical analysis would have been of little value 
due to the small panel of experts and was therefore not done.  A quantitative analysis 
from the provided feedback was performed to determine common feedback and concerns 
for the adoption of this evidence-based protocol.  
Table 1  
Survey Questions 
 
Ethical Considerations 
The ethical considerations for this project were minimally related to all presented 
recommendations have been endorsed by leading anesthesia organizations and supported 
by evidence-based and peer-reviewed literature.  Specific concerns center around the 
Questions  Response 1 Response 2 Response 3 
This best practice 
recommendation was 
presented clearly. 
 
Strongly Agree Strongly Agree Strongly Agree 
The presented 
information is of high 
quality. 
 
Strongly Agree Strongly Agree Strongly Agree 
The information is 
relevant to clinical  
practice. 
 
Strongly Agree Strongly Agree Strongly Agree 
Do you believe that 
this best practice 
recommendation 
should be 
implemented in your 
facility? 
 
Yes Yes Yes 
Please provide any 
additional comments 
and/or suggestions. 
Add mock drills   
Alternative to lipids if 
unavailable to facility 
None 
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facility’s inability to provide access to intralipid or supplies as well as adherence to 
protocol.  Limited access to the necessary supplies and knowledge deficit can lead to the 
potential of providing a level of care not based on the latest evidence-based research. 
Summary 
Informal interviews were done with anesthesia administration and anesthesia 
providers.  After an analysis of the feedback, the data shows that many hospitals lack the 
best practice clinical policy regarding the treatment for local anesthetic systemic toxicity.  
A literature search was performed to analyze best practice guidelines for LAST 
prevention and treatment.  The available knowledge was synthesized in order to compile 
a report of findings.  This report of findings, along with the ASRA Checklist for 
Treatment of LAST, was be presented to a panel of experts.  An evaluation tool was used 
to gather feedback on the presented data.  The feedback guided revision of the policy 
recommendations and develop an executive summary.  The executive summary and 
policy recommendation were then presented to the Chief CRNA for consideration of 
implementation.  
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CHAPTER III  - RESULTS 
This DNP project’s goal was to develop the best practice recommendation for the 
treatment of local anesthetic systemic toxicity in a Mississippi hospital.  A report of 
findings was presented to the panel of experts, along with the ASRA’s checklist for 
Treatment of LAST, an evaluation tool (ASRA, 2017) was used to determine the quality 
of information presented, relevance to clinical practice, and potential for implementation 
of the protocol.  Additionally, each responding member of the expert panel was provided 
the opportunity for further comments and suggestions in the form of the evaluation tool. 
The panel of experts was comprised of the Chief CRNA, a pharmacist, a 
registered nurse frequently involved with regional anesthesia, and a health policy expert.  
Each member of this panel was chosen due to their familiarity with local anesthetic use, 
availability of resources, and familiarity with policy development.  The responses and 
recommendations from this expert panel were reviewed and incorporated into an 
executive summary that was presented to the Chief of the Anesthesia Department for 
consideration, along with an accompanying educational module.  The educational module 
featured a pre- and post-test based on the information in the executive summary.  The 
project was intended that this module may be used in order to help with the 
implementation of this best practice recommendation. 
One member of the panel of experts was not able to be reached at the time of the 
presentation.  The responses are described in Table 1.  All participants strongly agreed 
that the information was presented clearly.  They also strongly agreed that the 
information was of high quality and relevant to clinical practice.  Finally, all participants 
reported that this best practice recommendation should be implemented.  None of the 
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panel members had ever experienced an event of LAST, echoing findings in the review 
of medical database literature that demonstrated the rarity of LAST occurrence.  One 
participant had an additional comment, “this hospital practices mock drills to familiarize 
the staff with the location of needed supplies.  The drill includes identifying the location 
of the intralipid medication.”  The recommendation was added to the executive summary.  
Another recommendation was for an alternative to lipid infusion for hospitals that did not 
have access to it.  While the literature does not support an alternative at this time, the best 
practice protocol that was recommended lists all the other steps that should be taken.  
Without the use of intralipid, cardiopulmonary bypass may be needed, as resuscitation 
may be prolonged (ASRA, 2018). 
Summary 
A best practice protocol was presented to a selected hospital-based panel of 
experts, along with a treatment checklist that was developed by the ASRA.  The expert 
panel was then asked to complete an evaluation and provide any wanted comments or 
recommendations.  All the respondents strongly agreed that the information was clearly 
presented, of high quality, and relevant to their practice.  They also reported that the best 
practice recommendation should be followed in their facility.  The recommended idea of 
mock drills to be prepared for a possible LAST event was an idea that is worthy of future 
research. 
 
.
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CHAPTER IV – DISCUSSION 
Summary 
This project was undertaken with the intent of decreasing the potential negative 
consequences of LAST, while also increasing provider confidence in the ability to treat 
such events.  The literature review led to the discovery of a Checklist for Treatment of 
LAST (ASRA, 2017).  This checklist, along with supporting evidence, was used to 
develop a best practice recommendation that was presented to a panel of experts.  The 
recommendation was presented to stakeholders at a USM affiliated hospital for input.  
The feedback was then used to reinforce an Executive Summary (Appendix F) that was 
sent to the panel upon completion. 
Interpretation 
The completed expert panel evaluations demonstrated the willingness to adopt 
this best practice recommendation into use.  The panel also provided potential areas of 
improvement in the recommendation.  These areas of recommended improvements 
included mock drills to reinforce the recommendations.  Additionally, one panelist 
questioned the treatment options if lipids were not available, a concern that was 
addressed in the executive summary.  The panel’s responses and comments helped to 
solidify the information presented in the executive summary. 
Limitations 
This project’s results were limited by the small sample size of the panel that was 
presented and offered the opportunity to evaluate this project.  Presenting these findings 
to a larger audience would have provided the opportunity for more feedback and the 
potential for a wider range of responses.  While the review of literature featured 
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information from a wide range of practices, the evaluation and expert panel were from 
one hospital. 
Conclusion 
In conclusion, this doctoral project intended to improve the recognition and 
treatment of LAST.  From a review of the literature and informal interviews with 
anesthesia providers, the data showed that a knowledge deficit exists surrounding the 
treatment of LAST (Corcoran et al., 2006) (Appendix A).  Potential negative 
consequences of the failure to manage LAST include CNS toxicity, cardiac toxicity, and 
death (Dillane & Finucane, 2009).  A review of the literature was performed to identify 
the best practice for the treatment of LAST.  This information was compiled into a Report 
of Findings that was then presented to a panel of experts.  After presenting the 
information, the panel of experts was asked to fill out a brief evaluation and provide any 
comments they would like regarding the information provided.  The panel unanimously 
agreed that this best practice recommendation should be adopted in their clinical practice.  
Their feedback was considered when developing the final executive summary, which was 
presented to the anesthesia department along with an education module (Appendix-F) to 
be used to improve knowledge of LAST in their department.  Adoption of this best 
practice recommendation has the potential to prevent the CNS toxicity, cardiac toxicity, 
and deaths that may occur from improper recognition or treatment of LAST. 
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APPENDIX B – Literature Matrix 
Table A1.  
Literature Matrix 
Date of Publication 
Author/Editor’s 
Name 
Type of Evidence Summary 
February 2010 Manavi, M. V. Literature Review 
Evidence suggests 
that intralipid 
should be readily 
available in all 
areas where local 
anesthetics 
injections are 
performed and 
should be used as 
first-line treatment 
for local anesthetic 
toxicity.  However, 
the slow adoption 
by providers may 
endanger patients. 
October 2010 
Varela, H., 
Burns, S. M. 
Case Report 
The increasing 
number of case 
reports involving 
the successful use 
of lipid emulsion 
for the treatment of 
local anesthetic 
toxicity 
demonstrates the 
viability of 
intralipid rescue as 
a treatment 
modality. 
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Table A1 (continued). 
2017 
American Society of 
Regional Anesthesia 
and Pain Medicine 
Practice Advisory 
This practice 
advisory provides 
recommendations 
pertaining to 
prevention, 
recognition, and 
treatment of local 
anesthetic systemic 
toxicity. 
2017 
 
Barash, P. G., 
Cullen, B. F., 
Stoelting, R. K., 
Cahalan, M. K., 
Stock, C. M., 
Ortega, R., 
Holt, N. F. 
  
Book Chapter 
The use of local 
anesthetics in the 
form of neuraxial 
and peripheral 
anesthesia has the 
potential to 
improve patient 
outcomes. 
August 2018 
Nedialkov, A. M., 
Umadhay, T., 
Valdes, J. A., 
Campbell, Y. 
 
Best Practice and 
Review of 
Literature 
Lipid rescue should 
be readily available 
and used as a first-
line treatment for 
local anesthetic 
toxicity. 
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APPENDIX C – Report of Findings 
LAST is a rare, but potentially fatal complication of administering local anesthetic 
medications.  LAST can quickly lead to the central nervous system and cardiac 
compromise (Tetzlaff, 2000).  This treatment differs in a few key areas from 
conventional treatment of cardiac arrest, and therefore should be approached in a 
different, more precise manner (Dillane & Finucane, 2009).  For example, calcium 
channel blockers and lidocaine are commonly used to treat the arrhythmias that arise in a 
patient with cardiac compromise (Tetzlaff, 2000).  However, these medications will lead 
to a further decline in the patient with LAST.  While the most effective treatment for 
LAST has been well established, it was found through both reviews of literature and 
survey of clinical preceptors that its rarity makes it a condition that most providers have 
not encountered in clinical practice (Manavi, 2010; Nedialko et al., 2018).  Additionally, 
lipid emulsion use remains controversial among anesthesia providers although it has been 
shown to drastically improve resuscitation following LAST (Nedialkov et al., 2018). 
While the occurrence of LAST is rare, failure to treat or incorrect treatment of 
LAST has the potential to result in patient injury or death (Barash et al., 2017; Sites et al., 
2012).  From the review of the literature and informal interviews with anesthesia 
providers, evidence was found that a knowledge deficit exists surrounding the treatment 
of LAST (Corcoran et al., 2006).  Potential negative consequences of the failure to 
manage LAST include CNS toxicity, cardiac toxicity, and death (Dillane & Finucane, 
2009).  To address this gap in knowledge, a best practice recommendation was compiled 
based on current evidence-based literature.  The best practice recommendation was used 
to create a treatment protocol that will be presented to anesthesia administration at a 
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USM clinical affiliate hospital, along with an educational tool to facilitate dissemination 
of the information.   
The symptoms of LAST most frequently appear within the first few minutes of 
injection of a local anesthetic. LAST most often occurs because of inadvertent 
intravascular injection of local anesthetic or a higher than the therapeutic dose (Barash, 
Cullen, & Stoelting, 2017).  LAST symptoms occur in the central nervous system (CNS), 
and/or the cardiovascular system.  CNS symptoms can lead to respiratory depression, 
coma, and eventually death. Cardiovascular symptoms are seen at a higher plasma 
concentration than that which leads to CNS symptoms (Barash et al., 2017).  While all 
LA’s can cause hypotension, dysrhythmias and myocardial depression, more potent 
agents, such as bupivacaine, ropivacaine, and levobupivacaine, are predisposed to 
devastating outcomes such as cardiovascular collapse and complete heart block (Barash 
et al., 2017).  The exact mechanism that induces LAST is not clearly understood. To 
quote Clinical Anesthesia (Barash, 2017), “The underlying pathophysiology responsible 
for local anesthetic-induced cardiovascular collapse has not been fully established” 
(Barash et al., 2017, p. 576).  “Local anesthetics readily cross the blood-brain barrier and, 
as a result, CNS toxicity can occur with systemic absorption or inadvertent intravascular 
injections” (Barash et al., p. 575).  The ease of diffusion across the blood-brain barrier 
explains why in some cases, confusion and seizure activity precedes cardiovascular 
symptoms.  An especially dangerous drug that can present with cardiac symptoms is 
bupivacaine.  “Bupivacaine has an inherently greater affinity for binding resting and 
inactivated cardiac sodium channels than lidocaine” (Barash et al., 2017 p. 577). 
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Prevention of LAST 
With the morbidity and mortality associated with LAST, every effort should be 
made to prevent intravascular injection.  No single intervention has been proven to 
definitively eliminate the risk of LAST.  Steps must be taken to avoid intravascular 
injection and elevated blood concentration of the LA during the performance of the 
regional technique.  “Aspiration prior to injection of LA and the use of an intravascular 
marker such as epinephrine reduces the likelihood of accidental intravascular injection to 
a large extent” (Yaddnapudi, 2011, para. 2).  The use of ultrasound-guided regional 
anesthesia (UGRA) is a topic that is being explored.  In theory, visualization of anatomic 
structures and medication spread should reduce adverse outcomes associated with 
regional anesthesia, including LAST.  Due to the extreme rarity of this complication, a 
statistically significant difference between nerve localization techniques, if indeed any 
difference exists, will likely never be realized.  However, there exists conflicting 
evidence of whether UGRA results in a true reduction of LAST (Neal & Richard, 2010). 
Evidence-Based Practice for Treatment of LAST 
The American Society of Regional Anesthesia and Pain Medicine (ASRA) 
updated the checklist for the management of LAST as recently as 2017.  The 
recommendations are described as “fundamentally different from conventional 
cardiopulmonary resuscitation.  Insofar as toxic cardiomyopathy differs from other 
causes of CV collapse” (Neal & Barrington, 2017, para. 5).  These guidelines recommend 
early airway support over immediate cardiac support.  This approach prioritizes the 
prevention of hypercarbia and subsequent acidosis that can potentiate LAST.  This article 
states succinctly, “Successful treatment of LAST seeks to effectively moderate or reverse 
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the mechanisms underlying the local anesthetic toxicity” (Neal & Barrington, 2017, para. 
6).  Data retrieved from rat studies reinforce the practice of administering small doses of 
epinephrine when patient condition indicates (1mcg/kg or less) (Neal & Barrington, 
2017).  “Lipid therapy is recommended at the first sign of arrhythmia, prolonged seizures, 
or rapid clinical deterioration of the patient” (Neal & Barrington, 2017, para. 8).  The 
exact mechanism of action for lipid therapy is unknown, but several theories exist.  The 
“lipid sink” theory states that the intravenous infusion of lipids creates a lipid 
compartment in which the local anesthetic will be drawn, lowering the effective dose in 
the aqueous plasma (Manavi, 2010).  Other theories are related to the lipids increasing 
available energy for cardiac muscle contraction (Nedialkov et al., 2018).  Multiple case 
reports demonstrate successful resuscitation following local anesthetic toxicity when 
intralipid are used as early treatment (Valera & Burns, 2010).  However, the use of 
intralipid therapy remains controversial among anesthesia providers (Nedialkov et al., 
2018). 
Existing Protocols 
As stated before, in 2017 the American Society of Regional Anesthesia and Pain 
Medicine (ASRA) updated the checklist for the treatment of local anesthetic system 
toxicity treatment.  Recommendations by The Association of Anaesthetists of Great 
Britain and Ireland (2010) and Medscape (2019) echo the treatment described by the 
ASRA.  The initial treatment suggested is to stop or limit the insulating substance and get 
help. If serious signs of LAST occur, consider limpid emulsion therapy immediately 
(ASRA, 2017).  Because of the gravity of a cardiovascular event from LAST, notifying 
the nearest cardiopulmonary bypass team is also recommended.  Providers are 
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encouraged to ventilate with 100% oxygen, avoid hypoventilation, and insert advanced 
airway if needed to control seizures. Benzodiazepines are the preferred method of seizure 
management.  Propofol is to be avoided due to its cardiac depressive properties. If the 
patient weighs greater than 70 kilograms, a bolus of 100ml 20% lipid emulsion over a 2-
3-minute period is recommended, followed by an infusion of 200-250 milliliters over 15-
20 minutes.  For a patient, less than 70 kilograms a bolus of 1.5 milligrams-per-kilogram 
(ideal body weight) lipid emulsion over 2-3 minutes, followed with an infusion of 0.25 
milligram-per-kilogram is recommended.  With a dosing limit of 12 milligrams-per-
kilogram, the total volume of lipid emulsion can approach 1 liter in a prolonged 
resuscitation (ASRA, 2017).  The Checklist for Treatment of Local Anesthetic Systemic 
Toxicity is included at the end of this document.   
Summary 
There are many benefits of local anesthetic use, including decreased length of 
hospital stay, increased pain control, decreased pulmonary complications, decreased 
opioid use, and even increased survival rates in some cases (Baresh et. al., 2017).  For 
these reasons, the practice of regional anesthesia is on the rise.  As with any anesthetic 
procedure, there are always risks that must be acknowledged and properly managed.  
True LAST is a rare event; thus, most anesthesia providers have not encountered it in 
training or clinical practice.  The rarity leads to a possible gap in provider understanding 
of the proper treatment for LAST.  Evidence shows that the use of checklists or protocols 
can improve the selection of the appropriate treatment modality in uncommonly 
encountered clinical events (Harrison et al., 2006; Ziewacz et al., 2011).  Therefore, a 
LAST treatment protocol is presented in order to ensure an effective treatment in the 
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event of LAST.  The protocol will be recommended to be readily available in all 
operative environments where local anesthetics are to be administered.  
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Checklist for Treatment of Local Anesthetic Systemic Toxicity (LAST) 
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(ASRA, 2017). 
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APPENDIX D – Evaluation Tool 
Please circle your answers to the following questions. 
1.  This best practice recommendation was presented clearly. 
Strongly Disagree  Disagree Neutral Agree  Strongly Agree 
2.  The presented information is of high quality. 
Strongly Disagree  Disagree Neutral Agree  Strongly Agree 
3.  The information is relevant to clinical practice. 
Strongly Disagree  Disagree Neutral Agree  Strongly Agree 
4.  Do you believe that this best practice recommendation should be implemented in your 
facility?  Yes  No 
5.  If you answered “No” to question 4, please briefly explain your answer. 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________ 
6.  Please provide any additional comments and/or suggestions below. 
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
_______________________________________________________________________ 
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APPENDIX E – DNP Essentials 
Table A2.  
DNP Essentials 
DNP Essentials Clinical Implications 
Essential One: Scientific Underpinnings 
for practice 
Research of evidence-based protocols to 
manage an anesthesia-crisis. 
Essential Two: Organizational and 
Systems Leadership for Quality 
Improvement and Systems Thinking 
Involving department leaders in the 
development of a cognitive aid to 
improve patient care. 
Essential Three: Clinical Scholarship and 
Analytical Methods for Evidence-Based 
Practice 
Synthesis and analysis of available 
knowledge for the treatment of local 
anesthetic systemic toxicity. 
Essential Four: Information 
Systems/Technology and Patient Care 
Technology for the Improvement and 
Transformation of Health Care 
Introduction of a cognitive aid to guide to 
improve patient outcomes from a 
potential anesthetic crisis. 
Essential Five: Health Care Policy for 
Advocacy in Health Care. 
This project advocates for the 
implementation of a cognitive aid for use 
in identifying and treating local anesthetic 
systemic toxicity. 
Essential Six: Interprofessional 
Collaboration for Improving Patient and 
Population Health Outcomes 
Communication with an interdisciplinary 
panel of experts on proposed protocol and 
seeking feedback on how to implement in 
a real-world situation. 
Essential Seven: Clinical Prevention and 
Population Health for Improving the 
Nation’s health 
Potential prevention of negative sequelae 
by guiding the correct treatment of a 
LAST event. 
Essential Eight: Advanced Nursing 
Practice 
Interpreting available knowledge to 
determine best practice, identifying a 
relevant guideline, and assessing the 
potential implementation of said evidence 
into clinical practice. 
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APPENDIX F – Executive Summary 
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This document is an executive summary of full report Developing a LAST 
Protocol in a Mississippi Hospital.  The student registered nurse anesthetists performed a 
literature review regarding the best practice recommendations for the treatment of LAST.  
These findings, along with a potential protocol for using best practice recommendations, 
were presented to a panel of experts to determine suitability for these recommendations 
in clinical practice.   
Report of Findings 
Local anesthetic systemic toxicity (LAST) is a rare, but potentially fatal 
complication of administering local anesthetic medications.  LAST can quickly lead to 
the central nervous system and cardiac compromise (Tetzlaff, 2000).  Its treatment differs 
in a few key areas from conventional treatment of cardiac arrest, and therefore should be 
approached in a different, more precise manner (Dillane & Finucane, 2009).  For 
example, calcium channel blockers and lidocaine are commonly used to treat the 
arrhythmias that arise in a patient with cardiac compromise (Tetzlaff, 2000).  However, 
these medications will lead to a further decline in the patient with LAST.  While the most 
effective treatment for LAST has been well established, it was found through both 
reviews of literature and survey of clinical preceptors that its rarity makes it a condition 
that most providers have not encountered in clinical practice (Manavi, 2010; Nedialkov et 
al., 2018).  Additionally, although lipid emulsion has been shown to drastically improve 
resuscitation following local anesthetic systemic toxicity, its use remains controversial 
among anesthesia providers (Nedialkov et al., 2018). 
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While the occurrence of LAST is rare, failure to treat or incorrect treatment of 
LAST has the potential to result in patient injury or death (Barash et al., 2017; Sites et al., 
2012).  With the recent movement towards reducing opioid use, as well as, the increasing 
use of ultrasound for peripheral nerve blocks, local anesthetics use is on the rise.  From 
the review of the literature and informal interviews with anesthesia providers, the authors 
found that a knowledge deficit exists surrounding the treatment of LAST (Corcoran et al., 
2006).  Potential negative consequences of the failure to manage LAST include CNS 
toxicity, cardiac toxicity, and death (Dillane & Finucane, 2009).  To address this gap in 
knowledge, a best practice recommendation was compiled based on current evidence-
based literature. The best practice recommendation was used to create a treatment 
protocol that will be presented to anesthesia administration at a USM clinical affiliate 
hospital, along with an educational tool to facilitate dissemination of the information. 
The symptoms of LAST almost always appear within the first few minutes of 
injection of a local anesthetic. LAST most often occurs because of inadvertent 
intravascular injection of local anesthetic or a higher than the therapeutic dose (Barash et 
al., 2017).  LAST symptoms occur in the central nervous system (CNS), and/or the 
cardiovascular system.  CNS symptoms can lead to respiratory depression, coma, and 
eventually death. Cardiovascular symptoms are seen at a higher plasma concentration 
than that which leads to CNS symptoms (Barash et al., 2017). While all LA’s can cause 
hypotension, dysrhythmias and myocardial depression, more potent agents, such as 
bupivacaine, ropivacaine, and levobupivacaine, are predisposed to devastating outcomes 
such as cardiovascular collapse and complete heart block (Barash et al., 2017).  The exact 
mechanism that induces LAST is not clearly understood. To quote Clinical Anesthesia 
 40 
(Barash et al., 2017). “The underlying pathophysiology responsible for local anesthetic-
induced cardiovascular collapse has not been fully established” (Barash et al., 2017, p. 
576). “Local anesthetics readily cross the blood-brain barrier and, as a result, CNS 
toxicity can occur with systemic absorption or inadvertent intravascular injections 
(Barash et al., 2017). This action explains why in some cases, confusion and seizure 
activity precedes cardiovascular symptoms.  An especially dangerous drug that can 
present with cardiac symptoms is bupivacaine. “Bupivacaine has an inherently greater 
affinity for binding resting and inactivated cardiac sodium channels than lidocaine” 
(Barash et al., 2017, p. 577). 
Prevention of LAST 
With the morbidity and mortality associated with LAST, every effort should be 
made to prevent intravascular injection.  No single intervention has been proven to 
definitively eliminate the risk of LAST.  Steps must be taken to avoid intravascular 
injection and elevated blood concentration of the LA during the performance of the 
regional technique. “Aspiration before injection of LA and the use of an intravascular 
marker such as epinephrine reduces the likelihood of accidental intravascular injection to 
a large extent.” (Yaddnapudi, 2011, para. 2). The use of ultrasound-guided regional 
anesthesia (UGRA) is a topic that is being explored. In theory, visualization of anatomic 
structures and medication spread should reduce adverse outcomes associated with 
regional anesthesia, including LAST.  Due to the extreme rarity of this complication, a 
statistically significant difference between nerve localization techniques, if indeed any 
difference exists, will likely never be realized. There appears to be conflicting evidence 
of whether UGRA results in a true reduction of LAST (Neal & Richard, 2010). 
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Evidence-Based Practice for Treatment of LAST  
The American Society of Regional Anesthesia and Pain Medicine (ASRA) 
updated the checklist for the management of LAST as recently as 2017. The 
recommendations are described as “fundamentally different from conventional 
cardiopulmonary resuscitation. Insofar as toxic cardiomyopathy differs from other causes 
of CV collapse” (Neal & Barrington, 2017, para. 5). These guidelines recommend early 
airway support over immediate cardiac support. This approach prioritizes the prevention 
of hypercarbia and subsequent acidosis that can potentiate LAST. This article states 
succinctly, “Successful treatment of LAST seeks to effectively moderate or reverse the 
mechanisms underlying the local anesthetic toxicity” (Neal & Barrington, 2017, para. 6).  
Data retrieved from rat studies reinforce the practice of administering small doses of 
epinephrine when patient condition indicates (1mcg/kg or less) (Barrington, 2017).  
“Lipid therapy is recommended at the first sign of arrhythmia, prolonged seizures, or 
rapid clinical deterioration of the patient” (Neal & Barrington, 2017, para. 8).  The exact 
mechanism of action for lipid therapy is unknown, but several theories exist.  The “lipid 
sink” theory states that the intravenous infusion of lipids creates a lipid compartment in 
which the local anesthetic will be drawn, lowering the effective dose in the aqueous 
plasma (Manavi, 2010).  Other theories are related to the lipids increasing available 
energy for cardiac muscle contraction (Nedialkov et al., 2018).  Multiple case reports 
demonstrate successful resuscitation following local anesthetic toxicity when intralipid is 
used as early treatment (Valera & Burns, 2010).  However, the use of intralipid therapy 
remains controversial among anesthesia providers (Nedialkov et al., 2018).  
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Existing Protocols 
As stated previously, in 2017 the American Society of Regional Anesthesia and 
Pain Medicine (ASRA) updated the checklist for the treatment of local anesthetic system 
toxicity treatment. Recommendations by The Association of Anaesthetists of Great 
Britain and Ireland (2010) and Medscape (2019) echo the treatment described by the 
ASRA.  The suggested initial intervention is to stop the injecting the local anesthetic and 
get help.  If serious signs of LAST occur, consider lipid emulsion therapy immediately 
(ASRA, 2017, p. 1).  Because of the gravity of a cardiovascular event from LAST, 
notifying the nearest cardiopulmonary bypass team is also recommended.  Providers are 
encouraged to ventilate with 100% oxygen, avoid hypoventilation, and insert advanced 
airway if needed to control seizures.  Benzodiazepines are the preferred method of 
seizure management.  Propofol is to be avoided due to its cardiac depressive properties. If 
the patient weighs greater than 70 kg, a bolus of 100 ml 20% lipid emulsion over a 2-3-
minute time period is recommended, followed by an infusion of 200-250 ml over 15-20 
minutes.  For a person less than 70 kg, a bolus of 1.5 ml/kg (ideal body weight) lipid 
emulsion over 2-3-minutes, followed with an infusion of 0.25 ml/kg is recommended.  
With a dosing limit of 12 mL/kg, the total volume of lipid emulsion can approach 1 L in a 
prolonged resuscitation (ASRA, 2017).  The Checklist for Treatment of Local Anesthetic 
Systemic Toxicity is included at the end of this document.    
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Summary 
Literature shows many benefits of local anesthetic use, including decreased length 
of hospital stay, increased pain control, decreased pulmonary complications, decreased 
opioid use, and even increased survival rates in some cases (Baresh et al., 2017).  For 
these reasons, its practice is on the rise.  As with any anesthetic procedure, there are 
always risks that must be acknowledged and properly managed.  True local anesthetic 
systemic toxicity is a rare event; thus, most anesthesia providers have not encountered it 
in training or clinical practice.  This leads to a possible gap in provider understanding of 
the proper treatment for LAST.  Evidence shows that the use of checklists or protocols 
can improve the selection of the appropriate treatment modality in uncommonly 
encountered clinical events (Harrison, Manser, Howard, & Gaba, 2006; Ziewacz, 
Arriaga, Bader et al., 2011).  Therefore, a local anesthetic systemic toxicity treatment 
protocol is presented in order to ensure an effective treatment in the event of LAST.  It 
was recommended that this protocol be readily available in all operative environments 
where local anesthetics are to be administered.  The authors also recommend that the pre- 
and post-test be used, as well as, mock drills in order to train the anesthesia staff on the 
proper treatment of LAST. Worth noting is the fact that in the event that lipids are not 
available, cardiopulmonary bypass may be needed, as resuscitation may be prolonged 
(ASRA, 2018). 
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(ASRA, 2017).  
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APPENDIX G – Pre- and Post-Test Evaluations 
Pre-Test Evaluation 
1. Management of a LAST event can be managed with standard ACLS protocols for 
optimal outcomes? True or False 
2. The first line mediation for treatment of LAST induced seizures is. A. Propofol B. 
Intralipid C. Phenytoin D. Benzodiazepines  
3. Which medication is proven to be the most beneficial in the treatment of LAST at 
the first sign of cardiac arrhythmia, prolonged seizures, or rapid clinical 
deterioration of the patient? A. Amiodarone B. Epinephrine C. Lidocaine D. 
Intralipid 
4. The Initial dose of intralipid for a patient greater than 70 kg is? A. 50 ml B. 200 
ml C. 100 ml D. 25 ml 
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Post Test Evaluation 
1. Management of a LAST event can be managed with standard ACLS protocols for 
optimal outcomes? True or False 
2. The first line mediation for treatment of LAST induced seizures is. A. Propofol B. 
Intralipid C. Phenytoin D. Benzodiazepines  
3. Which medication is proven to be the most beneficial in the treatment of LAST at 
the first sign of cardiac arrhythmia, prolonged seizures, or rapid clinical 
deterioration of the patient? A. Amiodarone B. Epinephrine C. Lidocaine D. 
Intralipid 
4. The Initial dose of intralipid for a patient greater than 70 kg is? A. 50 ml B. 200 
ml C. 100 ml D. 25 ml 
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Answer Key: 
1. False 
2. D. Benzodiazepines 
3. D. Intralipid 
4. C. 100 ml 
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